Shares of Calumet, Inc. (NASDAQ:CLMT - Get Free Report) dropped 4.9% during trading on Monday. The company traded as low as $55.27 and last traded at $54.9120. 455,667 shares traded hands during trading, a decline of 64% from the average session volume of 1,253,353 shares. The stock had previously closed at $57.75.
Analyst Upgrades and Downgrades
Several research analysts have weighed in on CLMT shares. Weiss Ratings reiterated a "sell (d-)" rating on shares of Calumet in a research report on Friday, August 7th. The Goldman Sachs Group boosted their price objective on shares of Calumet from $40.00 to $45.00 and gave the company a "neutral" rating in a research report on Tuesday, August 18th. TD Cowen upped their price objective on Calumet from $34.00 to $40.00 and gave the stock a "hold" rating in a research note on Wednesday, August 12th. UBS Group raised their target price on Calumet from $26.00 to $47.00 and gave the stock a "neutral" rating in a report on Tuesday, August 25th. Finally, HC Wainwright raised their target price on Calumet from $60.00 to $75.00 and gave the stock a "buy" rating in a report on Wednesday, September 2nd. One investment analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus price target of $51.75.
View Our Latest Report on Calumet
Calumet Trading Down 5.9%
The company has a market cap of $4.78 billion, a P/E ratio of -35.08, a PEG ratio of 1.54 and a beta of 0.78. The business's 50 day simple moving average is $53.19 and its 200 day simple moving average is $41.92.
Calumet (NASDAQ:CLMT - Get Free Report) last posted its quarterly earnings results on Friday, August 7th. The oil and gas company reported ($1.09) earnings per share for the quarter, missing analysts' consensus estimates of $0.07 by ($1.16). The business had revenue of $1.45 billion for the quarter, compared to analyst estimates of $1.12 billion. Calumet's revenue for the quarter was up 40.8% on a year-over-year basis. During the same period in the prior year, the firm posted ($1.70) EPS. Sell-side analysts anticipate that Calumet, Inc. will post 0.76 EPS for the current year.
Institutional Investors Weigh In On Calumet
A number of institutional investors have recently added to or reduced their stakes in CLMT. Two Seas Capital LP purchased a new position in Calumet during the 2nd quarter valued at approximately $238,442,000. Bank of America Corp DE purchased a new stake in shares of Calumet during the 2nd quarter worth approximately $35,348,000. Renaissance Technologies LLC bought a new position in shares of Calumet during the 1st quarter valued at approximately $14,066,000. State Street Corp boosted its position in shares of Calumet by 12.7% during the 2nd quarter. State Street Corp now owns 3,471,065 shares of the oil and gas company's stock valued at $125,028,000 after acquiring an additional 390,906 shares during the last quarter. Finally, Hennessy Advisors Inc. bought a new position in shares of Calumet during the 2nd quarter valued at approximately $10,201,000. 34.41% of the stock is owned by hedge funds and other institutional investors.
Calumet Company Profile
(
Get Free Report)
Calumet, Inc NASDAQ: CLMT is a specialty products and renewable fuels company headquartered in Indianapolis, Indiana. The company develops, produces and markets a range of products derived from crude oil and renewable feedstocks for industrial, commercial and consumer applications.
Its specialty products portfolio includes lubricants, solvents, waxes, asphalt and other hydrocarbon-based products, as well as products used in manufacturing, transportation, infrastructure and consumer goods.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Calumet, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Calumet wasn't on the list.
While Calumet currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.